Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer.

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in Biotechnology

www.allogene.com →

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Alerts

News

ROSEN, THE FIRST FILING FIRM, Encourages Richtech Robotics Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm - RR

ILMN Stock Gains Following Expanded Collaboration With Labcorp

PEG Set for Steady Growth on Clean Energy Investments & Strong Demand

Can GEV Capitalize on the Exploding Power Demand From AI Data Centers?

Beyond Defense: Drone ETFs Flying High Amid the Middle East Crisis

AMD vs. Broadcom: Which Semiconductor Stock is a Buy Right Now?

ICL Strengthens Specialty Fertilizers With New India Facility

Constitution of the Board of Directors in Genmab A/S and Grant of Restricted Stock Units and Warrants to Employees in Genmab

Meta backtracks on decision to end Horizon Worlds VR after fans speak up

Vivian Tung Talks Active Opportunities, MFS ETFs, and More

How Robotics & Nuclear Are Powering Next-Gen AI

EWZ: In Addition To The Donroe Doctrine, There Are New Catalysts For This ETF

ETF of the Week: SPDR Gold MiniShares Trust (GLDM)

Blockbuster Earnings, Falling Shares: A Trader's Guide to Micron

Trump Is No Crusader for Markets. Why the Fed Failed to Deliver the Holy Grail.

Meta Platforms is Overvalued at 6.01X PS: Buy or Hold the Stock?

Saltz Mongeluzzi Bendesky Lauds Pennsylvania PUC Enforcement Action Against Negligent UGI Gas Utility Linked to the March 24, 2023 Mass-Casualty Fatal Gas Explosion At R. M. Palmer Candy Factory

Blue-Chip Tech Stock Could Topple Overhead Resistance

VGTel, Inc. Releases Follow-Up EEG Study Results, Establishing Baseline for Consciousness Research Integrated with UAP and Astronomy Initiatives

GARTNER, INC. (IT) INVESTOR ALERT Investors With Large Losses in Gartner, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

About